|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for EIF1AX |
 Gene summary |
| Basic gene Info. | Gene symbol | EIF1AX |
| Gene name | eukaryotic translation initiation factor 1A, X-linked | |
| Synonyms | EIF1A|EIF1AP1|EIF4C|eIF-1A|eIF-4C | |
| Cytomap | UCSC genome browser: Xp22.12 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001412.3, | |
| Description | Putative eukaryotic translation initiation factor 1AeIF-1A X isoformeukaryotic translation initiation factor 1A, X chromosomeeukaryotic translation initiation factor 1A, X-chromosomaleukaryotic translation initiation factor 4C | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 300186 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000173674 | ||
| HPRD : 02174 | ||
| Vega : OTTHUMG00000022704 | ||
| Protein | UniProt: P47813 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_EIF1AX | |
| BioGPS: 1964 | ||
| Pathway | NCI Pathway Interaction Database: EIF1AX | |
| KEGG: EIF1AX | ||
| REACTOME: EIF1AX | ||
| Pathway Commons: EIF1AX | ||
| Context | iHOP: EIF1AX | |
| ligand binding site mutation search in PubMed: EIF1AX | ||
| UCL Cancer Institute: EIF1AX | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID |
| Top |
| Ligand binding site mutations for EIF1AX |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | H60 | I61L | LUAD | 1 | W70 | W70C | UCEC | 1 | P2 | P2S | UCEC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for EIF1AX |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | P2 | P2S | -1.2483263 | W70 | W70C | -1.1178059 | H60 | I61L | -0.62333255 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for EIF1AX from PDB |
| Top |
| Differential gene expression and gene-gene network for EIF1AX |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for EIF1AX |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| umls:C0220633 | Uveal melanoma | 2 | Biomarker |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for EIF1AX |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of EIF1AX go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | NUC | Nucleic Acids | 4kzz | n | H60 | NUC | Nucleic Acids | 4kzz | n | W70 |
| Top |
| Conservation information for LBS of EIF1AX |
| Multiple alignments for P47813 in multiple species |
| LBS | AA sequence | # species | Species | D98 | LKYNADEARSL | 2 | Homo sapiens, Mus musculus | D98 | HKYNLDEARTL | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | D98 | LKYTADEARTL | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | G43 | VIKMLGNGRLE | 2 | Homo sapiens, Mus musculus | G43 | ITKMLGNGRVE | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | G43 | VTKMLGNGRIE | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | G45 | KMLGNGRLEAM | 2 | Homo sapiens, Mus musculus | G45 | KMLGNGRVEAS | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | G45 | KMLGNGRIEAA | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | H60 | VKRLCHIRGKL | 1 | Homo sapiens | H60 | NKRMAHIRGKL | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | H60 | VRRLCHIRGKL | 1 | Mus musculus | H60 | VKRLGHIRGKL | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | K3 | 4 | Homo sapiens, Saccharomyces cerevisiae (strain ATCC 204508 / S288c), Mus musculus, Schizosaccharomyces pombe (strain 972 / ATCC 24843) | K64 | CHIRGKLRKKV | 2 | Homo sapiens, Mus musculus | K64 | AHIRGKLRKKV | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | K64 | GHIRGKLRKKV | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | K67 | RGKLRKKVWIN | 3 | Homo sapiens, Mus musculus, Schizosaccharomyces pombe (strain 972 / ATCC 24843) | K67 | RGKLRKKVWMG | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | K68 | GKLRKKVWINT | 2 | Homo sapiens, Mus musculus | K68 | GKLRKKVWMGQ | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | K68 | GKLRKKVWINQ | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | L42 | QVIKMLGNGRL | 2 | Homo sapiens, Mus musculus | L42 | QITKMLGNGRV | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | L42 | QVTKMLGNGRI | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | M41 | AQVIKMLGNGR | 2 | Homo sapiens, Mus musculus | M41 | AQITKMLGNGR | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | M41 | AQVTKMLGNGR | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | N44 | IKMLGNGRLEA | 2 | Homo sapiens, Mus musculus | N44 | TKMLGNGRVEA | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | N44 | TKMLGNGRIEA | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | P2 | 4 | Homo sapiens, Saccharomyces cerevisiae (strain ATCC 204508 / S288c), Mus musculus, Schizosaccharomyces pombe (strain 972 / ATCC 24843) | R46 | MLGNGRLEAMC | 2 | Homo sapiens, Mus musculus | R46 | MLGNGRVEASC | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | R46 | MLGNGRIEAAC | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | R66 | IRGKLRKKVWI | 3 | Homo sapiens, Mus musculus, Schizosaccharomyces pombe (strain 972 / ATCC 24843) | R66 | IRGKLRKKVWM | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | W70 | LRKKVWINTSD | 2 | Homo sapiens, Mus musculus | W70 | LRKKVWMGQGD | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | W70 | LRKKVWINQGD | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |